Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
The Danish biotech company confirmed the global study will begin in the second half of 2026
The Danish biotech company confirmed the global study will begin in the second half of 2026
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Subscribe To Our Newsletter & Stay Updated